Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
68.30 USD   +4.42%
09/30Aao 2022 : Treatment of Geographic Atrophy Secondary to AMD with Pegcetacoplan: Two-Year Outcomes from the Randomized Phase 3 OAKS and DERBY Trials
PU
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on APELLIS PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) APELLIS PHARMACEUTICALS, INC.
Analyst Recommendations on APELLIS PHARMACEUTICALS, INC.
09/12Wedbush Raises Price Target on Apellis Pharmaceuticals to $67 From $55, Sees Increased Pro..
MT
09/08Stifel Nicolaus Adjusts Price Target on Apellis Pharmaceuticals to $65 From $60, Keeps Buy..
MT
09/07B. Riley Downgrades IVERIC bio to Sell from Neutral After 'Disappointing' Data Which Reaff..
MT
08/25Analyst recommendations: Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, ..
MS
08/24Wedbush Adjusts Apellis Pharmaceuticals Price Target to $55 From $45, Maintains Neutral Ra..
MT
08/09Credit Suisse Raises Apellis Pharmaceuticals' Price Target to $52 from $49, Updates Model ..
MT
08/09Raymond James Adjusts Price Target on Apellis Pharmaceuticals to $113 From $102, Reiterate..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 68,30 $
Average target price 77,82 $
Spread / Average Target 13,9%
High Price Target 113,00 $
Spread / Highest target 65,4%
Low Price Target 40,00 $
Spread / Lowest Target -41,4%
Consensus detail
Consensus revision (last 18 months)